In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St Jude pays DOJ $3.7m to settle rebate and false claims probe

This article was originally published in RAJ Devices

St Jude Medical has agreed to pay the US Department of Justice $3.7 million to resolve an investigation into alleged kickbacks made by the company to two hospitals1.

The St Paul, Minnesota, firm came under scrutiny in July 2007 after a whistleblower accused it of giving rebates to Parma Community General Hospital (Parma, Ohio) and Norton Healthcare (Louisville, Kentucky) on purchases of the company's heart devices. These kickbacks caused false claims to be submitted to federal healthcare programmes in violation of the False Claims Act, the DOJ alleged.

St Jude has not admitted liability or wrongdoing, though it did say that the government's claims centred on "small, isolated product rebates that the company paid more than five years ago". In settling this agreement, St Jude stated that it would avoid "the potential costs and risks associated with litigation".

The company said that the settlement would have no material impact on its financial position or operations.

Nearly $4m total settlement

In addition to St Jude's $3.7m, Parma Hospital and Norton Healthcare will be paying the government $40,000 and $133,300, respectively, to resolve the investigation2. Jerry Hudson, the whistleblower, will get $640,000 as his share of the settlement.

References

1. St Jude Medical press release, 4 June 2010, http://investors.sjm.com/phoenix.zhtml?c=73836&p=irol-newsArticle&ID=1434818

2. DOJ press release, 4 June 2010, www.justice.gov/opa/pr/2010/June/10-civ-658.html

Latest Headlines
See All
UsernamePublicRestriction

Register

SC096130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel